Sartorius Stock Forecast for 2023 - 2025 - 2030
Updated on 03/28/2024
Sartorius Stock Forecast and Price Target
The average price target for Sartorius's stock of 350.50€ recently provided by ten leading analysts would represent a -2.26% downside from its last closing price if reached. This potential increase is based on a high estimate of 390.00€ and a low estimate of 240.00€. If you're looking to buy Sartorius stock, you may also want to check out its rivals.
-2.26% Downside
Sartorius Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Sartorius's Price has seen a drop from 255.66€ to 0.00€ – a 100.00% decrease. In the next year, analysts expect Fair Value to reach 342.05€ – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
TMO Stock Forecast | Thermo Fisher Scientific | Outperform |
10
|
$599.43 | Buy/Sell | $591.94 | 0.10% |
ROG Stock Forecast | Roche Holding | Hold |
16
|
CHF242.00 | Buy/Sell | CHF307.83 | 11.57% |
AZN Stock Forecast | AstraZeneca PLC | Outperform |
17
|
£104.50 | Buy/Sell | £165.99 | 53.79% |
DHR Stock Forecast | Danaher | Outperform |
10
|
$252.80 | Buy/Sell | $260.33 | 2.85% |
MRK Stock Forecast | Merck KGaA | Outperform |
18
|
156.75€ | Buy/Sell | 190.06€ | 9.73% |
Sartorius Revenue Forecast for 2023 - 2025 - 2030
Sartorius's Revenue has increased by 45.39% In the last three years, going from 2.34€B to 3.40€B. In the next year, analysts expect Revenue to reach 3.81€B – an increase of 12.16%. For the next seven years, the forecast is for Revenue to grow by 102.80%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$239.50 | Buy/Sell | $284.47 | 16.91% |
PH Stock Forecast | Parker-Hannifin Corp | Outperform |
10
|
$536.04 | Buy/Sell | $548.76 | 7.10% |
A Stock Forecast | Agilent Technologies | Outperform |
10
|
$147.29 | Buy/Sell | $138.82 | 1.84% |
Sartorius Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Sartorius's Dividend per Share has grown, increasing from 0.70€ to 0.74€ – a growth of 5.71%. The next year looks promising for Sartorius, with analysts predicting Dividend per Share of 0.90€ – an increase of 21.62%. Over the next seven years, experts anticipate that Sartorius's Dividend per Share will grow at a rate of 155.41%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BIIB Stock Forecast | Biogen | Outperform |
10
|
$230.07 | Buy/Sell | $299.62 | 29.09% |
BAYN Stock Forecast | Bayer | Hold |
5
|
26.82€ | Buy/Sell | 45.15€ | 26.77% |
MTD Stock Forecast | Mettler-Toledo International | Hold |
13
|
$1.30k | Buy/Sell | $1.12k | -7.55% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
STE Stock Forecast | STERIS | Outperform |
13
|
$233.84 | Buy/Sell | $238.33 | 4.77% |
ENTG Stock Forecast | Entegris | Outperform |
18
|
$139.37 | Buy/Sell | $116.12 | 2.96% |
RGEN Stock Forecast | Repligen | Outperform |
16
|
$193.14 | Buy/Sell | $187.18 | 12.61% |
Sartorius EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Sartorius's EBITDA has grown from 646.75€M to 817.70€M – a 26.43% increase. Next year, analysts are expecting EBITDA to reach 1.18€B – an increase of 44.06%. Over the next seven years, the forecast is for EBITDA to grow by 261.29%.
Sartorius EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Sartorius's EBIT has grown by 6.95%, rising from 510.13€M to 545.60€M. For next year, analysts predict EBIT of 827.36€M, which would mean an increase of 51.64%. Over the next seven years, experts predict that Sartorius's EBIT will grow at a rate of 255.14%.
Sartorius EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Sartorius's EPS has seen a drop from 4.38€ to 0.00€ – a 100.00% decrease. In the next year, analysts expect EPS to reach 5.86€ – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.